谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 4 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ASSESSING THE NET FINANCIAL BENEFITS OF EMPLOYING DIGITAL ENDPOINTS IN CLINICAL TRIALS
Joseph A. DiMasi,Abigail Dirks,Zachary Smith, Sarah Valentine,Jennifer C. Goldsack, Thomas Metcalfe,Upinder Grewal,Lada Leyens, Ute Conradi,Daniel Karlin, Lesley Maloney,Kenneth A. Getz,Bert Hartog
CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 8 (2024)
引用0浏览0WOS引用
0
0
Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration
Lada Leyens, John Batchelor, Erwin De Beuckelaer, Kai Langel,Bert Hartog
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCHno. 6 (2024): 731-741
引用0浏览0WOS引用
0
0
Unlocking the Full Potential of Digital Endpoints for Decision Making: a Novel Modular Evidence Concept Enabling Re-Use and Advancing Collaboration
Lada Leyens, J. S. Batchelor, Erwin De Beuckelaer, Kai Langel,Bert Hartog
Expert review of pharmacoeconomics & outcomes researchpp.1-11, (2024)
引用0浏览0引用
0
0
Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies
Spencer Phillips Hey, Maria Dellapina, Kristin Lindquist,Bert Hartog,Jason LaRoche
Therapeutic innovation & regulatory scienceno. 6 (2023): 1269-1278
引用0浏览0WOS引用
0
0
作者统计

#Papers: 4

#Citation: 0

H-Index: 0

G-Index: 0

Sociability: 2

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn